AMERIGEN PHARMACEUTICALS Trademark

Trademark Overview

On Monday, May 2, 2011, a trademark application was filed for AMERIGEN PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the AMERIGEN PHARMACEUTICALS trademark a serial number of 85310012. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 12, 2014. This trademark is owned by AMERIGEN PHAMACEUTICALS, LTD.. The AMERIGEN PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of hypertension, depression, cardiovascular disease, allergies, neurological disorders, gastro-intestinal disease, and pain
amerigen pharmaceuticals

General Information

Serial Number85310012
Word MarkAMERIGEN PHARMACEUTICALS
Filing DateMonday, May 2, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 12, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 10, 2012

Trademark Statements

Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesPharmaceutical preparations for the prevention and treatment of hypertension, depression, cardiovascular disease, allergies, neurological disorders, gastro-intestinal disease, and pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 5, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAMERIGEN PHAMACEUTICALS, LTD.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGrand Cayman KY1-1111
KY
Party NameAMERIGEN PHAMACEUTICALS, LTD.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGrand Cayman KY1-1111
KY

Trademark Events

Event DateEvent Description
Monday, May 12, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 12, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, October 11, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 10, 2013EXTENSION 2 GRANTED
Monday, October 7, 2013EXTENSION 2 FILED
Monday, October 7, 2013TEAS EXTENSION RECEIVED
Wednesday, May 1, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2013EXTENSION 1 GRANTED
Monday, April 8, 2013EXTENSION 1 FILED
Tuesday, April 30, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 8, 2013TEAS EXTENSION RECEIVED
Tuesday, October 9, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 24, 2012EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, May 7, 2012EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 10, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2012PUBLISHED FOR OPPOSITION
Wednesday, March 21, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 7, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 7, 2012ASSIGNED TO LIE
Friday, February 17, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 16, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 15, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 15, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 15, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 15, 2011NON-FINAL ACTION E-MAILED
Monday, August 15, 2011NON-FINAL ACTION WRITTEN
Friday, August 12, 2011ASSIGNED TO EXAMINER
Thursday, May 5, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 5, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals amerigen disease neurological allergies disorders gastro pain intestinal cardiovascular prevention preparations